Metlife (MET) Common Equity (2009 - 2026)

Metlife's Common Equity history runs 18 years deep, the most recent figure standing at $27.3 billion for Q1 2026.

• On a quarterly basis, Common Equity fell 1.55% year-over-year to $27.3 billion in Q1 2026; TTM through Mar 2026 was $27.3 billion, a 1.55% decrease from a year earlier, with the FY2025 full-year figure at $28.7 billion, up 3.53% from the prior year.
• Common Equity eased to $27.3 billion in Q1 2026 per MET's latest filing, from $28.7 billion in the prior quarter.
• Across five years, Common Equity topped out at $42.7 billion in Q1 2022 and bottomed at $25.9 billion in Q3 2023.
• The 5-year median for Common Equity is $28.9 billion (2025), against an average of $30.1 billion.
• Across the five-year window, Common Equity plunged 57.25% in 2022 and gained 20.35% in 2024, its largest moves.
• Year by year, Common Equity stood at $30.1 billion in 2022, then increased by 0.42% to $30.3 billion in 2023, then decreased by 8.43% to $27.7 billion in 2024, then gained by 3.53% to $28.7 billion in 2025, then declined by 4.73% to $27.3 billion in 2026.
• Per Business Quant, the three latest MET Common Equity figures stand at $27.3 billion (Q1 2026), $28.7 billion (Q4 2025), and $28.9 billion (Q3 2025).